Abstract Number: 1555 • 2018 ACR/ARHP Annual Meeting
Quality of Life of Rheumatoid Arthritis Patients Treated with Biologics
Background/Purpose: Major advances in the management of rheumatoid arthritis (RA) have been recorded over the last decade thanks to the introduction of biologics. However, medical…Abstract Number: 1556 • 2018 ACR/ARHP Annual Meeting
How Phenotype of the Small Fibre Neuropathy in Primary Sjögren Syndrome Differs from Others Causes of Small Fibre Neuropathy ?
Background/Purpose: Small fibre neuropathy (SFN) is a peripheral neuropathy characterized by neuropathic pain associated with normal routine nerve conduction study but rarefaction of intraepidermal nerve…Abstract Number: 1557 • 2018 ACR/ARHP Annual Meeting
Visualization of Dorsal Root Ganglionitis with Three-Tesla Magnetic Resonance Neurography in Sensory Ataxic Neuropathy Associated with Sjögren’s Syndrome
Background/Purpose: Sjögrenfs syndrome (SS)-associated neuropathy manifests as various forms of neuropathy, including sensory ataxic neuropathy (SAN). Dorsal root ganglionitis, pathologically defined as the lymphocytic infiltration…Abstract Number: 1558 • 2018 ACR/ARHP Annual Meeting
Intravenous Immunoglobulin Efficacy for Primary Sjögren’s Syndrome Associated Small Fiber Neuropathy
Background/Purpose: To analyze the efficacy and tolerance of intravenous immunoglobulin (IVIG) therapy in 11 patients with primary Sjögren's syndrome (pSS)-associated small-fiber neuropathy (SFN).Methods: Retrospective, single-center…Abstract Number: 1559 • 2018 ACR/ARHP Annual Meeting
Development of Lymphoma in Patients with Sjogren’s Syndrome
Background/Purpose: Non-Hodgkin lymphoma (NHL) is one of the most feared complications of primary Sjogren's syndrome (pSS). The most frequent is MALT type lymphoma, with localization…Abstract Number: 1560 • 2018 ACR/ARHP Annual Meeting
Usefulness of 18F-FDG Positron Emission Tomography for Lymphoma Diagnosis in Patients with Primary Sjögren’S Syndrome
Background/Purpose: primary Sjögren’s syndrome (SS) is the autoimmune disease having the highest risk of lymphoma. The differential diagnosis between benign and malignant lymphoproliferation is sometimes…Abstract Number: 1561 • 2018 ACR/ARHP Annual Meeting
B Lymphocyte Depletion Therapy with Rituximab in Primary Sjögren’s Syndrome: Indications , Effectiveness and Ultrasonographic Response
Background/Purpose: Aim of this study was to assess indications, effectiveness, clinical and ultrasonographic response to rituximab (RTX) therapy in primary Sjögren’s syndrome (pSS), focusing in…Abstract Number: 1562 • 2018 ACR/ARHP Annual Meeting
Large Granular Lymphocyte Proliferations in Primary Sjögren’s Syndrome: An Iatrogenic Manifestation
Background/Purpose: Large granular lymphocyte (LGL) proliferations can be observed in some auto-immune disorders, especially rheumatoid arthritis. However, reports of LGL proliferations in primary Sjogren’s syndrome…Abstract Number: 1563 • 2018 ACR/ARHP Annual Meeting
Risk of Overall Malignancies in Korean Patients with Primary Sjögren Syndrome
Background/Purpose: A significant association has been found between primary Sjögren syndrome (pSS) and non-hodgkin's lymphoma (NHL), but few studies have been conducted to explore the…Abstract Number: 1564 • 2018 ACR/ARHP Annual Meeting
Severe, Life-Threatening Phenotype of Primary Sjögren Syndrome: Clinical Characterization and Outcomes in 1580 Patients (GEAS-SS Registry)
Background/Purpose: To analyse the clinical features and outcomes of patients presenting with life-threatening systemic disease in a large cohort of Spanish patients with primary Sjogren…Abstract Number: 1565 • 2018 ACR/ARHP Annual Meeting
Comorbidity Burden in Primary Sjögren’s Syndrome: A Long-Term Observation in Clinical Practice
Background/Purpose: Primary Sjögren’s syndrome (pSS) is a complex disorder that may affect any organ and system. In this new era of personalized medicine, a growing…Abstract Number: 1566 • 2018 ACR/ARHP Annual Meeting
Prevalence and Prognosis of Interstitial Lung Disease in a Large Cohort of Chinese Primary Sjögren’s Syndrome Patients
Background/Purpose: To determine the prevalence and identify the prognosis associated with pulmonary involvement in pSS patients. Methods: A total of 1341 hospitalized patients (853 with…Abstract Number: 1567 • 2018 ACR/ARHP Annual Meeting
The Risk Factors and Prognosis of Interstitial Lung Disease Associated with Primary Sjogren’s Syndrome: A Multi-Center Cohort Study
Background/Purpose: The present study aimed to investigate the risk factors and prognosis of primary Sjogren’s syndrome-associated interstitial lung disease (pSS-ILD). Methods: Data were retrospectively collected…Abstract Number: 1568 • 2018 ACR/ARHP Annual Meeting
Azathioprine and Mycophenolate for Management of Sjögren’s Syndrome-Related Interstitial Lung Disease: A Retrospective Cohort Study
Background/Purpose: Interstitial lung disease (ILD) is a common extraglandular manifestation of Sjögren’s syndrome (SS). There is a paucity of literature on the management of SS-ILD.…Abstract Number: 1569 • 2018 ACR/ARHP Annual Meeting
Diagnostic Performance of Labial Salivary Gland Biosy, Serological and Clinical Data in Sjogrens Syndrome. in Argentinian Multicenter
Background/Purpose:Labial salivary gland biopsy (LSGB) is a safe and minimally invasive procedure used in the diagnostic evaluation of Sjogren’s Syndrome (SS). The objectives of this…
ACR Meeting Abstracts